Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials

Affiliations

• ¹ Department of Internal Medicine III, University Hospital Munich, Munich, Germany.
• ² Institute of Medical Informatics, Biometry, and Epidemiology, University of Munich, Munich, Germany.
• ³ Hematology Department, Rigshospitalet, Copenhagen, Denmark.
• ⁴ Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
• ⁵ HOVON Data Center, Erasmus MC Cancer Institute - Clinical Trial Center, Rotterdam, The Netherlands.
• ⁶ Department of Lymphoid Malignancies, The Maria Skłodowska-Curie Memorial Institute and Oncology Center, Warsaw, Poland.
• ⁷ Department of Internal Medicine III, University of Ulm, Ulm, Germany.
• ⁸ Institut Gustave Roussy, Villejuif, France.
• ⁹ Hospices Civils de Lyon, Université Claude Bernard, Pierre Bénite, France.
• ¹⁰ Department I of Internal Medicine, University of Cologne, Cologne, Germany.
• ¹¹ Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
• ¹² Oncology Department, The Norwegian Radium Hospital, Oslo, Norway.
• ¹³ Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.
• ¹⁴ Department of Hematology, Helsinki University Central Hospital, Helsinki, Finland.
• ¹⁵ Department of Oncology, Skane University Hospital, Lund, Sweden.
• ¹⁶ Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
• ¹⁷ Department of Pathology, Hematopathology Section and Lymph Node Registry, University of Kiel, Kiel, Germany.
• ¹⁸ Department of Hematology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, University Paris Descartes, Paris, France.
• ¹⁹ INSERM U1163 and CNRS 8254, Imagine Institute, Université Sorbonne Paris Cité, Paris, France.